Proceedings: A new muscle relaxant-AH8165.

[1]  B. Pleuvry,et al.  Some factors modifying the metabolism of AH 8165 by rat liver homogenate in vitro , 1973, The Journal of pharmacy and pharmacology.

[2]  D. Moyes,et al.  AH 8165: a new non‐depolarizing muscle relaxant , 1973, Anaesthesia.

[3]  T. M. Savege,et al.  The cardiovascular effects of AH 8165 , 1973, Anaesthesia.

[4]  R. Miller,et al.  Comparative antagonism of d-tubocurarine-, gallamine-, and pancuronium-induced neuromuscular blockades by neostigmine. , 1972, Anesthesiology.

[5]  L. E. Martin,et al.  Short-lasting, Competitive Neuromuscular Blocking Activity in a Series of Azobis-Arylimidazo-[1,2-a]-Pyridinium Dihalides , 1972, Nature.

[6]  G. A. Harrison,et al.  The Effect of Circulation Time on the Neuromuscular Action of Suxamethonium , 1972, Anaesthesia and intensive care.

[7]  P. Monks,et al.  The reversal of non–depolarising relaxants , 1972, Anaesthesia.

[8]  T. M. Savege,et al.  An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study. , 1972, Lancet.

[9]  J. McIntyre,et al.  Initial experience during the clinical use of pancuronium bromide. , 1971, Anesthesia and Analgesia.

[10]  R. Miller,et al.  Inhibition of succinylcholine-induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocaine. , 1971, Anesthesiology.

[11]  S. Feldman,et al.  A new theory of the termination of action of the muscle relaxants. , 1970, Proceedings of the Royal Society of Medicine.

[12]  S. Feldman,et al.  Diagnosis of non‐depolarising block , 1969, Anaesthesia.

[13]  R. Katz.  Neuromuscular Effects of d-Tubocurarine, Edrophonium and Neostigmine in Man , 1967, Anesthesiology.